Richard is the Chief Executive Officer and member of the board. Rick has substantial experience leading organizations both in clinical and commercial stages. Previously he was President of Minerva Neurosciences. Prior to that he was CEO of Greer Laboratories which he took public through a merger with Stallergenes PLC to create a global leader in Allergy Immunotherapy. He previously was Chief Commercial Officer at Sepracor/Sunovion where he led operations in the US, Canada and Europe generating over $2 billion in annual revenue. He previously served as a member of the board of the Massachusetts Biotechnology Council from 2012-2022.